Kestra Medical Technologies (KMTS) Long-Term Investments (2026)

Kestra Medical Technologies' (KMTS) quarterly Long-Term Investments came in at $65.8 million in Q2 2026.

Kestra Medical Technologies (KMTS) Long-Term Investments (2026) Analysis & Trends

Kestra Medical Technologies (KMTS) has 1 years of Long-Term Investments data on file, last reported at $65.8 million in Q2 2026.

  • On a quarterly basis, Long-Term Investments changed N/A year-over-year to $65.8 million in Q2 2026; TTM through Apr 2026 was $65.8 million, a N/A change from a year earlier, with the FY2026 full-year figure at $65.8 million, changed N/A from the prior year.
  • Long-Term Investments for Q2 2026 stood at $65.8 million.
  • Over the last five years, Long-Term Investments for KMTS reached as high as $65.8 million in Q2 2026 and fell as low as $65.8 million in Q2 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 800.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 3.41 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 207.70 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Kestra Medical Technologies 1.17 Bn 809.84 Mn 15.68 Mn 65.77 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 65.77 Mn